The RoMEO study: a real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cutaneous melanoma
L. Mortier,
N. Meyer,
J.-J. Grob,
M. Pouriel,
D. de Carpentier,
P. Saïag
Affiliations
L. Mortier
CHU Lille, Lille, France
N. Meyer
Clinique Médipôle Garonne, Toulouse, France
J.-J. Grob
AP-HM, Marseille, France
M. Pouriel
IT&Mstats provided for Novartis, Boulogne-Billancourt, France
D. de Carpentier
Novartis, Rueil-Malmaison, France
P. Saïag
Ambroise Paré Hospital, Boulogne-Billancourt, France
